Literature DB >> 1399452

Magnetic resonance imaging, microangiography, and histology in a rat model of primary liver cancer.

Y Ni1, G Marchal, B van Damme, P van Hecke, J Michiels, X Zhang, J Yu, A L Baert.   

Abstract

RATIONALE AND
OBJECTIVES: N-nitrosodiethylamine is able to induce various benign and malignant liver lesions in rats with a high success rate and a low mortality rate. It provides a more appropriate model that better simulates the various lesions occurring in patients than the usual model of tumor implantations.
METHODS: Hepatic carcinogenesis was induced in 58 Wistar rats using oral N-nitrosodiethylamine. The rats subsequently were studied by liver magnetic resonance imaging (MRI), postmortem microangiography, and histologic examination.
RESULTS: Hepatic tumors developed in 57 rats. A wide variety of the tumors in the degree of vascularization, the type of vessels, the areas of intratumoral secretion and necrosis, and the tumor cell differentiation resulted from the tumor model. The authors were able to assess the contribution of the vascular, extravascular, and cellular components in the final pattern of contrast enhancement in MRI.
CONCLUSIONS: The N-nitrosoethylamine model for hepatic tumor induction is simple, and provides a more representative range of tumors for experimental evaluation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1399452     DOI: 10.1097/00004424-199209000-00006

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  9 in total

1.  [Establishment of hepatocellular carcinoma model by allogenic transplantation ].

Authors:  J Qian; G Feng; J Trübenbach; P E Huppert; P L Pereira; C D Claussen
Journal:  J Tongji Med Univ       Date:  2001

Review 2.  Continuing pursuit for ideal systemic anticancer radiotherapeutics.

Authors:  Marlein Miranda Cona; Huaijun Wang; Junjie Li; Yuanbo Feng; Feng Chen; Peter de Witte; Alfons Verbruggen; Yicheng Ni
Journal:  Invest New Drugs       Date:  2011-10-18       Impact factor: 3.850

Review 3.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

4.  Diverse responses to vascular disrupting agent combretastatin a4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology.

Authors:  Junjie Li; Feng Chen; Yuanbo Feng; Marlein Miranda Cona; Jie Yu; Alfons Verbruggen; Jian Zhang; Raymond Oyen; Yicheng Ni
Journal:  Transl Oncol       Date:  2013-02-01       Impact factor: 4.243

5.  Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.

Authors:  Junjie Li; Raymond Oyen; Alfons Verbruggen; Yicheng Ni
Journal:  J Cancer       Date:  2013-01-22       Impact factor: 4.207

Review 6.  Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging.

Authors:  Binghu Jiang; Jichen Wang; Yicheng Ni; Feng Chen
Journal:  Theranostics       Date:  2013-08-10       Impact factor: 11.556

Review 7.  Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation.

Authors:  Yewei Liu; Shuncong Wang; Xiaohui Zhao; Yuanbo Feng; Guy Bormans; Johan Swinnen; Raymond Oyen; Gang Huang; Yicheng Ni; Yue Li
Journal:  Diagnostics (Basel)       Date:  2020-01-31

8.  Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P.

Authors:  Yewei Liu; Ting Yin; Frederik De Keyzer; Yuanbo Feng; Feng Chen; Jianjun Liu; Shaoli Song; Jie Yu; Vincent Vandecaveye; Johan Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Jian Zhang; Gang Huang; Yicheng Ni
Journal:  Oncotarget       Date:  2017-07-18

9.  Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.

Authors:  Ye-Wei Liu; Frederik De Keyzer; Yuan-Bo Feng; Feng Chen; Shao-Li Song; Johan Swinnen; Guy Bormans; Raymond Oyen; Gang Huang; Yi-Cheng Ni
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.